Acrivon Therapeutics announced the appointment of Jean-Marie Cuillerot, M.D., as chief medical officer. Dr. Cuillerot was previously the chief medical officer at Dragonfly Therapeutics where he established and led a clinical team advancing multiple potential first-in-class assets.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ACRV:
- Acrivon Therapeutics assumed with a Buy at Jefferies
- Acrivon Therapeutics files $300M mixed securities shelf
- Acrivon Therapeutics announces FDA has granted BDD for ACR-368
- Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Acrivon Therapeutics to Present at the Piper Sandler Annual Healthcare Conference
